Bandingkan Harga & Kinerja Multi Indocitra Tbk. (MICE) vs Brigit Biofarmaka Teknologi Tbk. (OBAT)
Kinerja harga (24 Jam Terakhir)
Statistik utama
Statistik utama
Perbedaan Multi Indocitra Tbk. dan Brigit Biofarmaka Teknologi Tbk.: Multi Indocitra Tbk. diperdagangkan di Rp520 (kapitalisasi pasar 312 M), sedangkan Brigit Biofarmaka Teknologi Tbk. diperdagangkan di Rp242 (kapitalisasi pasar 164,65 M, volume 24 jam 177,6 rb). Perbedaan utamanya: Multi Indocitra Tbk. lebih besar dari sisi kapitalisasi pasar. Mana yang lebih baik tergantung tujuan investasimu.
| MICE | OBAT | |
|---|---|---|
Kapitalisasi Pasar | 312 M | 164,65 M |
Volume | — | 177,6 rb |
Lot | — | 1,78 rb |
Perputaran | — | 42 jt |
Harga Rata-rata | — | 236,47 |
Nilai Transaksi | — | 42 jt |
Harga Ekuilibrium Indikatif | — | 242 |
Volume Ekuilibrium Indikatif | — | 500 |
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Berita terkini
Berita terbaru kedua aset
Berita terkini
Berita terbaru kedua aset
Tentang Multi Indocitra Tbk.
PT Multi Indocitra Tbk (the Company) was established under its original name of Modern Indocitra based on notarial deed No. 52 of Esther Daniar Iskandar, S.H dated January 11, 1990. The Company's articles of association has been amended several times, the latest amendment dated Aug 16, 2005, regarding the change in the Company's status from private company to public company.
Selengkapnya di halaman MICE →Tentang Brigit Biofarmaka Teknologi Tbk.
PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Selengkapnya di halaman OBAT →
